These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9154224)

  • 1. Reductionist science and Alzheimer's disease: redoubling our effort in redox chemistry.
    Wolozia B
    Mol Psychiatry; 1996 Nov; 1(5):352-5. PubMed ID: 9154224
    [No Abstract]   [Full Text] [Related]  

  • 2. RETRACTED ARTICLE: A needle from the haystack.
    Morris R; Mucke L
    Nature; 2006 Mar; 440(7082):284-5. PubMed ID: 16541054
    [No Abstract]   [Full Text] [Related]  

  • 3. Fibrillar and oligomeric beta-amyloid as distinct local biomarkers for Alzheimer's disease.
    Montalto MC; Farrar G; Hehir CT
    Ann N Y Acad Sci; 2007 Feb; 1097():239-58. PubMed ID: 17413026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of oxidized RNAs in Alzheimer's disease.
    Shan X; Lin CL
    Neurobiol Aging; 2006 May; 27(5):657-62. PubMed ID: 15979765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of association between clinical symptoms and postmortem indices of brain serotonin function in Alzheimer's disease.
    Lawlor BA; Ryan TM; Bierer LM; Schmeidler J; Haroutunian V; Mohs R; Davis KL
    Biol Psychiatry; 1995 Jun; 37(12):895-6. PubMed ID: 7548465
    [No Abstract]   [Full Text] [Related]  

  • 6. Neurochemical abnormalities in Alzheimer's disease and Parkinson's disease--a comparative review.
    Gsell W; Strein I; Krause U; Riederer P
    J Neural Transm Suppl; 1997; 51():145-59. PubMed ID: 9470135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of chronic brain hypoperfusion in the pathogenesis of Alzheimer's disease--facts and hypotheses].
    Zádori D; Datki Z; Penke B
    Ideggyogy Sz; 2007 Nov; 60(11-12):428-37. PubMed ID: 18198789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redox proteomics identification of oxidatively modified proteins in Alzheimer's disease brain and in vivo and in vitro models of AD centered around Abeta(1-42).
    Sultana R; Perluigi M; Butterfield DA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Mar; 833(1):3-11. PubMed ID: 16236561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The plasma membrane redox system in Alzheimer's disease.
    Adlard PA; Bush AI
    Exp Neurol; 2011 Mar; 228(1):9-14. PubMed ID: 21168407
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuroscience. Long-awaited technique spots Alzheimer's toxin.
    Helmuth L
    Science; 2002 Aug; 297(5582):752-3. PubMed ID: 12161622
    [No Abstract]   [Full Text] [Related]  

  • 11. Free radicals as mediators of toxicity in Alzheimer's disease: a review and hypothesis.
    Tabet N; Mantle D; Orrell M
    Adverse Drug React Toxicol Rev; 2000 Jun; 19(2):127-52. PubMed ID: 10967748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of mitochondrial dysfunction in Alzheimer's disease.
    Castellani R; Hirai K; Aliev G; Drew KL; Nunomura A; Takeda A; Cash AD; Obrenovich ME; Perry G; Smith MA
    J Neurosci Res; 2002 Nov; 70(3):357-60. PubMed ID: 12391597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes.
    Moreira PI; Santos MS; Seiça R; Oliveira CR
    J Neurol Sci; 2007 Jun; 257(1-2):206-14. PubMed ID: 17316694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid beta-peptide levels in laser capture microdissected cornu ammonis 1 pyramidal neurons of Alzheimer's brain.
    Aoki M; Volkmann I; Tjernberg LO; Winblad B; Bogdanovic N
    Neuroreport; 2008 Jul; 19(11):1085-9. PubMed ID: 18596605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine induces tau hyperphosphorylation in rats.
    Luo Y; Zhou X; Yang X; Wang J
    Neuroreport; 2007 Dec; 18(18):2005-8. PubMed ID: 18007203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal heterogenicity of amyloid protein examined in Alzheimer's disease.
    Pirim I; Erdogan AR; Tan U
    Int J Neurosci; 2004 Jan; 114(1):75-81. PubMed ID: 14660069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach.
    Sultana R; Poon HF; Cai J; Pierce WM; Merchant M; Klein JB; Markesbery WR; Butterfield DA
    Neurobiol Dis; 2006 Apr; 22(1):76-87. PubMed ID: 16378731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD.
    Sultana R; Boyd-Kimball D; Poon HF; Cai J; Pierce WM; Klein JB; Merchant M; Markesbery WR; Butterfield DA
    Neurobiol Aging; 2006 Nov; 27(11):1564-76. PubMed ID: 16271804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease.
    LaFerla FM
    Nat Rev Neurosci; 2002 Nov; 3(11):862-72. PubMed ID: 12415294
    [No Abstract]   [Full Text] [Related]  

  • 20. Alzheimer's disease as copper deficiency.
    Klevay LM
    Med Hypotheses; 2008; 70(4):802-7. PubMed ID: 17928161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.